Edition:
United States

Ibio Inc (IBIO.A)

IBIO.A on American Stock Exchange

0.30USD
18 Aug 2017
Change (% chg)

$0.00 (+1.67%)
Prev Close
$0.29
Open
$0.30
Day's High
$0.30
Day's Low
$0.28
Volume
11,058
Avg. Vol
24,164
52-wk High
$0.68
52-wk Low
$0.26

IBIO.A

Chart for IBIO.A

About

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformati... (more)
No analyst recommendations are available for IBIO.A.

Overall

Beta: 0.91
Market Cap(Mil.): $27.72
Shares Outstanding(Mil.): 92.82
Dividend: --
Yield (%): --

Financials

  IBIO.A Industry Sector
P/E (TTM): -- 31.45 32.56
EPS (TTM): -0.15 -- --
ROI: -41.96 15.33 14.89
ROE: -121.69 16.35 16.13

BRIEF-Ibio enters into common stock purchase agreement for up to $16 mln with Lincoln Park Capital

* Ibio Inc enters into common stock purchase agreement for up to $16.0 million with Lincoln Park Capital

Jul 24 2017

BRIEF-Ibio appoints James Mullaney as CFO

* On March 1, co appointed James P. Mullaney to serve as chief financial officer of company, replacing Mark Giannone

Mar 06 2017

Competitors

  Price Chg
Vical Incorporated (VICL.OQ) $2.43 +0.03
Novavax, Inc. (NVAX.OQ) $1.00 +0.01
Medicago Inc. (MDG.TO) -- --
Novartis AG (NOVN.S) CHF79.80 -0.85
GlaxoSmithKline plc (GSK.L) 1,490.00 -16.00
CSL Limited (CSL.AX) $128.61 +1.61
AstraZeneca plc (AZN.L) 4,447.00 -34.00
Merck Ltd (MERK.NS) Rs1,139.10 +10.55

Earnings vs. Estimates